ADIAL PHARMACEUTICALS, INC. (ADIL)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- 200,000
- Oct 4 · Unusual
- Form 4 sales
- 4
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Timeline
- 1 Form 4 salePlan not statedDec 12 2019
Sold 150,000 shares at $1.00 ($150k)
Johnson Bankole A., Chief Medical Officer
Sold 17.7% of holdings ($848k position)698,336 shares leftFirst sale on recordFiling
- 2 Form 4 saleUnusualAug 20 +252 days
Sold 350,000 shares at $1.21 ($424k)
Johnson Bankole A., Chief Medical Officer
Sold 99.7% of holdings ($425k position)1,055 shares leftFiling
- 3 Form 4 salePlan not statedApr 6 +229 days
Sold 150,000 shares at $2.50 ($375k)
Johnson Bankole A., Chief Medical Officer
Sold 21.5% of holdings ($1.7M position)548,336 shares leftFiling
- 4 Form 4 saleUnusualOct 4 +181 days
Sold 200,000 shares
Johnson Bankole A., Chief Medical Officer
Sold 57.4% of holdings148,246 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (4)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Johnson Bankole A. | Chief Medical Officer | Form 4 sale | 200,000 | 57.4% | Unusual | SEC | |
| Apr 6, 2021 | Johnson Bankole A. | Chief Medical Officer | Form 4 sale | 150,000 | $375k | 21.5% | Plan not stated | SEC |
| Aug 20, 2020 | Johnson Bankole A. | Chief Medical Officer | Form 4 sale | 350,000 | $424k | 99.7% | Unusual | SEC |
| Dec 12, 2019 | Johnson Bankole A. | Chief Medical Officer | Form 4 sale | 150,000 | $150k | 17.7% | Plan not stated | SEC |